Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin
Bloomberg
Friday, March 23, 2012 - 11:30am
tags:
lawsuits, Sanofi, Roche, Rituxan, Avastin, Genentech, Biogen Idec
Are Takeover Talk and Provenge Adding Optimism to Dendreon’s Biggest Institutional Shareholders?
Wall St. Cheat Sheet
Friday, March 23, 2012 - 11:29am
tags:
Provenge, prostate cancer, Dendreon, M&A
Aricept Drug Dosage Was Approved Despite Warning
NY Times, NY
Friday, March 23, 2012 - 11:28am
tags:
Aricept, Alzheimer's disease, FDA, Pfizer, Eisai
Lilly, Amylin receive European approval for expanded use of diabetes treatment Byetta
Yahoo/AP
Friday, March 23, 2012 - 11:27am
tags:
Eli Lilly, Amylin, Europe, diabetes, Byetta
Keryx, AEterna And The TREAT Act
Seeking Alpha
Friday, March 23, 2012 - 11:26am
tags:
Keryx, AEterna, TREAT Act, perifosine
Doctors Pressure FDA for Nonprescription Birth Control Pills
Bloomberg
Friday, March 23, 2012 - 11:25am
tags:
FDA, OTC, birth control pill, contraceptives
Obesity And The FDA: Why Qnexa Is Generating Buzz
Seeking Alpha
Thursday, March 22, 2012 - 5:35pm
tags:
FDA, obesity, Qnexa
Medical Group Blinks Amid Criticism Over Drug-Data Disclosure
WSJ Online
Thursday, March 22, 2012 - 5:29pm
tags:
physician data, EASL, hepatitis C, Abbott Laboratories, Bristol-Myers Squibb, Gilead
YM BiOSciences' Cheap Valuation Doesn't Make Sense
Seeking Alpha
Thursday, March 22, 2012 - 5:28pm
tags:
YM BioSciences
Why Abbott Labs Is Only Good For Dividends
Seeking Alpha
Thursday, March 22, 2012 - 5:27pm
tags:
Abbott Laboratories, dividends
Roche seen extending its Illumina offer once again
Reuters
Thursday, March 22, 2012 - 12:18pm
tags:
Roche, Illumina, M&A
Growing popularity of virtual biotechs promises boon to outsourcers
Fierce CRO
Thursday, March 22, 2012 - 12:16pm
tags:
outsourcing, virtual biotech, Shire, FerroKin, Stromedix, Biogen Idec
Is AZ aiming for a Forest buy?
Fierce Pharma
Thursday, March 22, 2012 - 12:14pm
tags:
AstraZeneca, Forest Labs, M&A
Don't Get Too Worked Up Over Johnson & Johnson's Earnings
Motley Fool
Thursday, March 22, 2012 - 12:11pm
tags:
earnings, JNJ
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Thursday, March 22, 2012 - 11:35am
tags:
Amyris, Aveo, China Biologic, Chelsea Therapeutics, Pluristem, Spectrum Pharmaceuticals, Questcor, Theravance, Vical, Zalicus
Corcept Therapeutics' Korlym to ship to patients by April 11
Yahoo/Fly on the Wall
Thursday, March 22, 2012 - 11:32am
tags:
Corcept Therapeutics, Korlym, Cushing's syndrome
Research shows Merck's prospective flushing drug may have another use: preventing baldness
NJ.com
Thursday, March 22, 2012 - 11:29am
tags:
Merck, baldness, Actelion
Next big cholesterol drugs in focus at meeting
Reuters
Thursday, March 22, 2012 - 11:28am
tags:
cardiology, PCSK9 inhibitor, REGN 727, Amgen, Merck, Regeneron
Icagen gets a new name after being acquired by Pfizer
News and Observer, NC
Thursday, March 22, 2012 - 11:27am
tags:
Pfizer, M&A, Icagen, Neusentis
Watson Buying Actavis? What The Wags Say…
Pharmalot
Thursday, March 22, 2012 - 11:26am
tags:
Watson, M&A, Actavis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.